Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Exelixis (EXEL) Stock Forecast & Price Target

→ Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad)
Free exel Stock Alerts
$20.57
+0.16 (+0.78%)
(As of 05/24/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends

Exelixis - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 17 Analyst Ratings

Consensus Price Target

$26.13
27.01% Upside
High Forecast$32.00
Average Forecast$26.13
Low Forecast$18.00
TypeCurrent Forecast
5/27/23 to 5/26/24		1 Month Ago
4/27/23 to 4/26/24		3 Months Ago
2/26/23 to 2/26/24		1 Year Ago
5/27/22 to 5/27/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
9 Buy rating(s)
12 Buy rating(s)
7 Buy rating(s)
Hold
7 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$26.13$26.29$25.94$25.33
Forecasted Upside27.01% Upside20.61% Upside23.56% Upside43.11% Upside

EXEL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EXEL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Exelixis Stock vs. The Competition

TypeExelixisMedical CompaniesS&P 500
Consensus Rating Score
2.59
2.70
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside27.01% Upside834.25% Upside9.92% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/14/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating		S. Loganathan
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageStrong-Buy ➝ Equal Weight$23.00+9.37%
5/3/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$28.00+27.85%
5/1/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$25.00 ➝ $27.00+27.96%
5/1/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform
4/11/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOverweight ➝ Equal Weight$25.00+5.57%
4/10/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMarket Outperform ➝ Market Outperform$27.00+14.55%
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
2/7/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$26.00 ➝ $28.00+35.46%
2/2/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHold ➝ Hold$23.00 ➝ $25.00+16.44%
12/19/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$27.00+15.68%
12/15/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$31.00+32.99%
11/2/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetEqual Weight ➝ Equal Weight$22.00 ➝ $23.00+14.26%
10/12/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$25.00 ➝ $27.00+25.58%
10/11/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$30.00+39.28%
9/13/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$32.00+45.12%
8/22/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$25.00 ➝ $29.00+35.70%
8/8/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating		C. Liu
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingMarket Perform
8/8/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform$18.00-11.11%
8/8/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform$18.00-11.11%
3/9/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOverweight$23.00+40.59%
3/3/2023EF Hutton Acquisition Co. I
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy$24.00+43.97%
2/8/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOverweight$32.00+81.82%
1/26/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$29.00+67.34%
1/9/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$21.00 ➝ $20.00+15.81%
11/2/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$26.00 ➝ $21.00+23.60%
6/23/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$28.00+31.27%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 05:53 PM ET.

EXEL Frequently Asked Questions

What is Exelixis's stock forecast and purchase recommendation?

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Exelixis is $26.13, with a high forecast of $32.00 and a low forecast of $18.00. The consensus rating for Exelixis stock is Moderate Buy based on the current 7 hold ratings and 10 buy ratings for EXEL. Learn more on EXEL's analyst rating history.

Do Wall Street analysts like Exelixis more than its competitors?

Analysts like Exelixis less than other "medical" companies. The consensus rating score for Exelixis is 2.59 while the average consensus rating score for "medical" companies is 2.70. Learn more on how EXEL compares to other companies.

Is Exelixis being downgraded by Wall Street analysts?

Over the previous 90 days, Exelixis's stock had 1 downgrade by analysts.

Does Exelixis's stock price have much upside?

According to analysts, Exelixis's stock has a predicted upside of 20.37% based on their 12-month stock forecasts.

What analysts cover Exelixis?

Exelixis has been rated by research analysts at Barclays, HC Wainwright, JMP Securities, Stephens, TD Cowen, and William Blair in the past 90 days.


Stock Forecasts and Research Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:EXEL) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks
Crypto 101 Media
WARNING about the death of the U.S. dollar…
Colonial Metals
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
$1,500 to $9,400 in one month? (A.I. Trade List)
Prosper Trading Academy
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Bill Gates is all about this tiny $2 stock
Timothy Sykes
New Options need New Trading Strategies
Netpicks
Write this ticker symbol down…
StocksToTrade